prostate cancer
| 3 min read
An immune checkpoint inhibitor and chemotherapy extended progression-free survival in late-stage small cell bladder and prostate cancers.
| 3 min read
A new study suggests that an extra cup of joe may help people survive longer with prostate cancer if they are fast caffeine metabolizers.
| 3 min read
Researchers use machine learning to identify generic drugs that are promising candidates for affordable and accessible cancer treatments.
| 3 min read
APIS, University of Virginia hope to leverage HULLK lncRNA as a prostate cancer biomarker
Page 1 of 1 - 4 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Supercharging cell line development and engineering with automated single cell sorting
Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
